Anodyne| Estazolam | |
|---|---|
 | |
| Molecular structure via molpic based on CDK |
| Conformer [] | |
|---|---|
| Physical properties [] | |
|---|---|
| Molecular mass | 294.74 g/mol [1] |
| Melting point | 228-229 [1] |
| Solubility | Practically insoluble (1.5 mg/L) [1] |
| Predicted LogP | 1.7 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C16H11ClN4 [1] |
| IUPAC name | 8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine [1] |
| SMILES | C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4 [1] |
| InChI | InChI=1S/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2 [1] |
| InChIKey | CDCHDCWJMGXXRH-UHFFFAOYSA-N [1] |
| Dosing [] | |
|---|---|
| Elimination half-life | 10 – 24 hours |
Estazolam
Estazolam (also known as Eurodin, Julodin, Esilgan, D 40TA, Estazolamum, 8-Chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine, Abbott 47631, Abbott-47631, Estazolam civ or 8-Chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine) is a
Chemistry
Stereochemistry []
Estazolam is a achiral mixture
Legal status
- Brazil: Estazolam is a B1 substance.[3]
- Canada: Estazolam is a Schedule IV substance.
- Germany: Estazolam is a prescription only/Anlage III substance.
- United Kingdom: Estazolam is a Class C substance.
- United States: Estazolam is a Schedule I under the "Controlled Substances Act (CSA)".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3261, Estazolam. Accessed June 26, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/3261
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Estazolam. UNII: 36S3EQV54C. Global Substance Registration System. Accessed June 26, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/36S3EQV54C
Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed June 26, 2025. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992